Search

for
Search:

GlossaryLiraglutide (GLP-1 receptor agonist)

medication mimicking GLP-1 hormone to regulate blood sugar

Liraglutide is a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1) to help regulate blood sugar levels and appetite. It is commonly used to treat type 2 diabetes under the brand name Victoza and for weight management under the brand name Saxenda.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 185 results

research GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

59 citations , August 2021 in “Frontiers in Endocrinology”

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

research Associations Between GLP-1 Receptor Agonists and Alopecia: A Multi-Center Retrospective Analysis and Public Interest Trends

October 2025 in “JEADV Clinical Practice”

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

research Hair Loss Associated With Glucagon-Like Peptide-1 Receptor Agonist Use: A Systematic Review

September 2025 in “Cureus”

GLP-1 receptor agonists may cause hair loss, but more research is needed.

research Alopecia as an Emerging Adverse Effect Associated with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss: A Scoping Review

August 2025 in “Cureus”

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

research Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review

February 2025 in “Skin Appendage Disorders”

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

View more "glp-1 receptor agonist" in research →

Community Join

5 / 21 results

community A New Hair Loss Drug Could Cure Balding and Reverse Graying

in Research/Science 362 upvotes 3 weeks ago

ABS-201, a prolactin receptor blocker, shows promise in reversing hair loss and graying, with early success in macaques. Current treatments like finasteride, minoxidil, and RU58841 are still widely used, but new options like PP405 are eagerly anticipated.

community Did UCLA Just Cure Baldness? Check this Out!

in Research/Science 969 upvotes 9 months ago

UCLA's PP405 shows promise in reactivating dormant hair follicles for hair loss treatment but is still in clinical trials. Minoxidil and finasteride remain common treatments until PP405 becomes available.

community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

in Female 54 upvotes 1 year ago

A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

community The end of balding: We may have just found the secret to hair regrowth

in Technology 676 upvotes 7 months ago

MCL-1 is important for hair follicle stem cell survival, but its impact on human hair regrowth is unclear. Minoxidil and finasteride are the main treatments, with doubts about new discoveries leading to effective human solutions soon.

community He used Dutasteride for 20 years. Interview

in Treatment 111 upvotes 11 months ago

Dutasteride has been used for 20 years with some hair thickness improvement but no dramatic regrowth. The user also experimented with minoxidil, tretinoin, and peptides like BPC 157 for potential benefits in hair density and quality.

View more "glp-1 receptor agonist" in community →